Wet macular degeneration occurs when abnormal blood vessels (known as choroidal neovascularization) grow under the macula. These new blood vessels may then bleed and leak fluid, causing the macula to bulge or lift up from its normally flat position, thus distorting or destroying central vision. It is called wet because of the fluid the leaks from the abnormal blood vessels. Patient with wet macular degeneration usually develop rapid vision loss over the course of weeks or months. Straight lines may look wavy because the macula is no longer smooth. Below is a discussion of various manifestations of wet AMD. Click the button to learn more about the treament of wet AMD
Treatment of Wet AMDChoroidal neovascular membranes are new blood vessels that grow beneath the retina and disrupt vision. These blood vessels grow in an area called the choroid, the area between the retina and the sclera (the white part of your eye). The choroid supplies oxygen and nutrients to the eye. These blood vessel growths break through the barrier between the choroid and the retina. Although one would think that more blood vessels supplying nutrients to the eye would be good, it is not. The new blood vessels grow out with scarring. Also, they leak more than normal retinal blood vessels. Finally they can bleed and blood is very harmful to the retina. Rarely patient maintain good vision with choroidal neovascular membranes (about 10 or 20 percent). Most people lose central vision rapidly who develop choroidal neovascular membranes unless they are treated.
Untreated, a person with a choroidal neovascular membrane will usually develop a submacular scar like the one in the photo. The scars are white because the are composed mostly of fibroblasts. Subretinal scars cause degeneration of the overlying retina and loss of vision. The scars are circular or disc shaped and therefore are called disciform scars. They cause vision loss because they block the transport of nutrients from the supporting tissue under the retina (the retinal pigment epithelium) which is vital to the survival and function of the retina. Unfortunately, once the retina has been permanently damaged by a submacular scar it cannot be resurrected. Retinal tissue does not regenerate. It cannot be replaced. Research is being pursued all over the world trying to find a way to fix damaged retinas, but nothing, at the moment (January 2015) is close to being effective.
A hallmark of wet AMD is subretinal fluid. This comes from leaking abnormal blood vessels under the macula. Their is not a firm attachment between the retina and the underlying retinal pigment epithelium. The retina is held in place against the underlying retinal pigment epithelium by a pump in the retinal pigment epithelium. This pump removes naturally occurring fluid in the subretinal space and keeps it dry. The leakage from a choroidal neovascular membrane overwhelms the natural pump in the retinal pigment epithelium and subretinal fluid accumulates. The subretinal fluid distorts the retina causing patients to see things as wavy instead of straight. It also decreases the supply of oxygen and nutrients to the retina and makes the vision blurry. Subretinal fluid is best dectected using optical coherence tomography. The photo shows a dark area under the retina where subretinal fluid has accumulated. The effect (or lack of effect) of treatments for wet macular degeneration is usually evaluated by monitoring the optical coherence tomography scan for subretinal fluid.
Most patients with wet AMD develop a retinal pigment epithelial detachment. The retinal pigment epithelium is a layer of cells under the retina that supports the retina. In the OCT image it is the bright white line closest to the bottom of the picture with RPE on top of it. (there are two lines, the line on the bottom is the RPE, the line on the top is the back of the retina). When fluid or lipid (fatty material) or blood vessels accumulates under the retinal pigment epithelium the retinal pigment epithelium is pushed up. The bump in the retinal pigment epithelium is called a pigment epithelial detachment. These are common in wet AMD. Treatment does not always cause the retinal pigment epithelial detachment to flatten. Vision can be excellent over a retinal pigment epithelial detachment. The distortion of the overlying retina will often cause distortion in the vision. Retinal pigment epithlial detachments do not compromise the ability of the retinal pigment epithelium to nurish the retina. Finally, you can develop a retinal pigment epithelial detachment without wet AMD. These retinal pigment epithelial detachments have lipid (fatty) material in them but no blood vessels. About 90 percent of retinal pigment epithelial detachments are associated with wet AMD and abnormal blood vessel growth.
Polypoidal choroidal vasculopathy is a subtype of wet AMD that is caused by a mature vascular complex under the retina. It is characterized by a branching vascular network with one or more polyps at the termini of the vessels. The branching vascular network and the polyp(s) are best seen with indocyanine green angiography. There is some evidence the polypoidal choroidal vasculaopathy (PCV) is less response to anti-VEGF injection therapy than other forms of wet AMD. In many cases photodynamic therapy is helpful in treating PCV.
Submacular hemorrhage (blood) is one of the most feared complications of wet AMD. The blood is toxic to the overlying retina and causes immediate severe vision loss. The photo shows blood in a patient whose vision dropped from 20/30 immediately to 20/1600 (no longer able to see even the big letters on the visual acuity chart). Fortunately, submacular hemorrhage is rare and occurs in only about 1 percent of patient with wet AMD. Once there is a submacular hemorrhage, vision almost never returns to what it was before the bleed. Treatment of wet AMD helps reduce the amount of vision loss. Surgery for submacular hemorrhage is controversial and may not be helpful. Visual recovery in someone with a submacular hemorrhage is very very slow. It usually takes about 6 months for the blood to absorb and then another 6-12 months for the overlying retina to heal. Vision usually improves some as the blood absorbs but not much. Most patients recover enough vision to see the big letters on the visual acuity chart but not enough vision to read.
FDA Approves Higher-Dose Aflibercept for Wet Macular … Everyday Health
FDA approves aflibercept injection 8mg for treatment of wet AMD … Ophthalmology Times
Is it AMD or vitelliform? Optometry Times
One-time Gene Therapy for Wet AMD Shows Potential | ASRS 2023 Managed Healthcare Executive
Geographic atrophy is a major concern in eye health Optometry Times
Certain inherited retinal diseases are characterized by large cystoid … Ophthalmology Times
Macular retinal detachment development associated with myopic … Ophthalmology Times Europe
How to Prevent Macular Degeneration Woman’s World
Eye health projects receive share of £13 million AI investment Association of Optometrists
Opthea announces nonproprietary drug name “sozinibercept” for … Optometry Times
FDA Approves Izervay: New Drug Slows Progression of Geographic … Everyday Health
Higher Aflibercept Dose Safe as 2 mg Medscape
ASRS 2023: Clinical characteristics of macular holes that close … Ophthalmology Times
Diabetes Dialogue: ADCES 2023 Recap MD Magazine
Macular degeneration causes, symptoms and treatments Nebraska Medicine
ASRS Live: Clearside Biomedical’s suprachoroidal injection platform … Ophthalmology Times
Macular Degeneration: Treatment for Dry and Wet Symptoms Verywell Health
Wet AMD: Researchers report one drug more effective treatment Medical News Today
Age-Related Macular Degeneration Vision Loss Management Verywell Health
Overview of Wet Age-Related Macular Degeneration (AMD) and … AJMC.com Managed Markets Network
Wet macular degeneration: Symptoms, causes, and more Medical News Today
Press Releases | Tuesday, Apr 25, 2023 SyncGene Blog
Age-related macular degeneration: Miniature telescope may help … Medical News Today
New treatment tackles both forms of AMD Ophthalmology Times
Eye Injections for Macular Degeneration (AMD) Treatment Verywell Health
FDA Approves Syfovre for Geographic Atrophy, a Potentially … Everyday Health
Podcast: Wet AMD and the treatment burden on patients Ophthalmology Times
Macular degeneration warning signs: What they look like and … Medical News Today
Macular degeneration and blindness: Possible links and more Medical News Today
Non age-related macular degeneration (MD): Causes and treatment Medical News Today
What is age-related macular degeneration? Open Access Government
Acupuncture for macular degeneration: What to expect Medical News Today
What are some signs of macular degeneration? Medical News Today
Dr Charles Wykoff: Gene Therapy for Wet AMD Would Be a … AJMC.com Managed Markets Network
Medicare and macular degeneration injections: What to know Medical News Today
Vision changes with MD: What it looks like, distance vision, and more Medical News Today
What medications are available for macular degeneration? Medical News Today
What to Expect with Intravitreal Injections for Age-Related Macular … University of Utah Health Care
Press Releases | Wednesday, Jul 19, 2023 SyncGene Blog
Extremely rare gene variants point to a potential cause of age … National Institutes of Health (.gov)
Here’s what you should know about macular degeneration Florida Today
Obesity linked to macular degeneration Science Daily
Eye-Opening Drug Discovery May Help Treat Age-Related Macular … Neuroscience News
Macular degeneration: Disability benefits and more Medical News Today